London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License ...

The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.

US FDA accepts for review GSK’s Blenrep combinations for the treatment of relapsed/refractory multiple myeloma: London, UK Tuesday, November 26, 2024, 09:00 Hrs [IST] GSK plc an ...

Trump Vows to Hit Mexico, Canada and China With Tariff on Day 1 President-elect Trump promised a 25 percent tariff on Canada and Mexico, and an additional 10 percent on China, blaming the flow of ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2397.45 as on 25 Nov, 2024, 12 ...

204 units proposed near Temple Health campus in North Philadelphia © 2024 American City Business Journals. All rights reserved. Use of and/or registration on any ...

It's impossible to miss, but at the same time it's 'hard to see'. However it's unquestionably the 'biggest issue' for this Australian capital, critics say. One Australian hunter said in his 50 ...

After hours: November 25 at 4:51 PM EST Loading Chart for SNY ...